Elon Musk’s Brain-Computer Interface
Founded in 2016 and publicly announced in 2017, Neuralink aimed to develop high-bandwidth brain-computer interfaces. #Neuralink exploded on social media due to Elon Musk’s involvement and ambitious goals: treating neurological conditions, enabling direct brain-to-computer communication, and eventually achieving “human-AI symbiosis.” The company’s flashy presentations contrasted with decades of quiet academic brain-interface research.
Live Demonstrations & Animal Testing
In 2020, Neuralink demonstrated Gertrude the pig with an implanted chip reading neural signals. A 2021 demonstration showed a monkey playing Pong using only brain signals. While impressive to public audiences, neuroscientists noted similar feats were achieved decades earlier. #Neuralink discussions debated whether the company offered genuine innovation or repackaged existing neurotechnology with better marketing.
Controversy & FDA Approval Journey
Animal welfare concerns emerged regarding Neuralink’s testing practices. Investigations revealed higher-than-expected animal mortality rates during development. The hashtag tracked FDA approval delays, with safety concerns about skull-mounted devices and electrode longevity. In May 2023, Neuralink received FDA approval for human trials, despite ongoing controversies.
First Human Implant & Future Claims
In January 2024, Neuralink announced its first human implant, with the participant able to control a computer cursor through thought. While significant for the individual, the medical brain-computer interface field already had FDA-approved devices from competitors. #Neuralink remains active in discussions about brain-computer interface ethics, accessibility, and Musk’s ambitious claims about future human enhancement.
Sources: